Form D · Biotechnology
Monocacy Therapeutics Inc.
Monrovia, MD · CIK 0002137361
Offering snapshot reported Oct 7, 2026 · SEC filing
- Reported sold
- $25K Offering amount: $25K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 25, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Sep 21, 2026 | Initial | $49 | No comparison | 1 | SEC filing |
| Aug 28, 2026 | Initial | Yet to sell | No comparison | 5 | SEC filing |
| Aug 28, 2026 | Amendment | $114,450 | $0vs May 27, 2026 | 2 | SEC filing |
| Aug 28, 2026 | Initial | $150,000 | No comparison | 1 | SEC filing |
| May 27, 2026 | Initial | $114,450 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600320
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Oct 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shashank Patel | Director, Executive |
| Suman Vodnala | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4716 Monrovia Blvd
Monrovia, MD, 21770
Phone: 3019790911
Monrovia, MD, 21770
Phone: 3019790911